✦ LIBER ✦

LETTER: A Randomized, Double-Blind, Placebo-Controlled Trial of Interferon-α and Amantadine Versus Interferon-α Alone in the Treatment of Patients with Chronic Hepatitis C

✍ Scribed by Jawad Ahmad; Hugo Vargas; Vijayan Balan; Jorge Rakela; A. Obaid Shakil

Book ID: 110341246
Publisher: Springer US
Year: 2002
Tongue: English
Weight: 36 KB
Volume: 47
Category: Article
ISSN: 0163-2116
DOI: 10.1023/a:1015804227191

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon and amantadine in naive chron

Interferon and amantadine in naive chronic hepatitis C: A double-blind, randomized, placebo-controlled trial

✍ Beat Helbling; Ivan Stamenic; Francesco Viani; Jean-Jacques Gonvers; Jean-Franco 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

A randomized trial of amantadine and int

A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C

✍ Alessandra Mangia; Nicola Minerva; Mauro Annese; Gioacchino Leandro; Maria Rosar 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled Trial of Interferon Alfa2a With and Without Amantadine as Initial Treatment for Chronic Hepatitis C

✍ Stefan Zeuzem; Gerlinde Teuber; Uta Naumann; Thomas Berg; Jochen Raedle; Susanne 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Combination therapy with thymosin α1 and

Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial

✍ Kenneth E. Sherman; Maria Sjogren; Robin L. Creager; Melissa A. Damiano; Stephen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Hepatitis C is a major cause of liver disease leading to cirrhosis. Although interferon (IFN) is the only approved therapy, treatment is characterized by low response rates and dose-limiting side effects. We evaluated the addition of thymosin ␣1 (TA1), an immunomodulatory peptide, to the standard tr

A randomized controlled trial of amantad

A randomized controlled trial of amantadine plus interferon-α2a vs. interferon-α2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-α2a monotherapy

✍ M. Angelico; M. Cepparulo; F. Angelico; S. Francioso; A. Barlattani; F. Di Candi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

A randomized, double-blind, controlled t

A randomized, double-blind, controlled trial of consensus interferon in the treatment of chinese patients with chronic hepatitis C

✍ Shinn-Jang Hwang; Shou-Dong Lee; Cho-Yu Chan; Rei-Hwa Lu; Full-Young Chang 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 56 KB